Nightingale Health Oyj (FRA:7XE)

Market Cap	74.24M -56.1%
Revenue (ttm)	4.80M -3.2%
Net Income	-19.07M
EPS	-0.32
Shares Out	n/a
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	n/a
Average Volume	7
Open	1.105
Previous Close	1.115
Day's Range	1.105 - 1.105
52-Week Range	1.105 - 2.920
Beta	n/a
RSI	41.78
Earnings Date	Jun 3, 2026

About Nightingale Health Oyj

Nightingale Health Oyj, a health technology company, offers advanced health check that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company’s Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Remote Health Check where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare...

• Industry: Medical Laboratories
• Founded: 2002
• Employees: 103
• Stock Exchange: Frankfurt Stock Exchange
• Ticker Symbol: 7XE

Financial Performance

In fiscal year 2025, Nightingale Health Oyj's revenue was 4.69 million, an increase of 7.69% compared to the previous year's 4.36 million. Losses were -18.46 million, 5.71% more than in 2024.